Belite Bio Q3 net loss widens on higher R&D expenses -February 2024-www.financetom.com

Belite Bio Q3 net loss widens on higher R&D expenses

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Belite Bio Q3 net loss widens on higher R&D expenses

Nov 10, 2025 5:33 AM

Overview

* Belite Bio ( BLTE ) reports Q3 net loss of $21.7 mln, increased from $8.7 mln last year

* Company completed $15 mln direct offering and $125 mln private placement

* China's NMPA and UK's MHRA accept Tinlarebant applications based on DRAGON trial

Outlook

* Company expects final DRAGON trial data in Q4 2025

* Company anticipates interim analysis for PHOENIX trial

* Company aims for regulatory milestones with Tinlarebant

Result Drivers

* INCREASED R&D EXPENSES - Driven by costs associated with DRAGON and PHOENIX trials, partially offset by Australian R&D tax incentive

* FINANCIAL STRENGTHENING - Completion of $15 mln direct offering and $125 mln private placement enhances financial position

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Net -$21.69

Income mln

Q3 -$23.02

Income mln

From

Operatio

Q3 $23.02

Operatin mln

Expenses

Q3 -$21.69

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the biotechnology & medical research peer group is "buy"

* Wall Street's median 12-month price target for Belite Bio Inc ( BLTE ) is $104.00, about 8.8% below its November 7 closing price of $113.19

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Previous page： This bank will cut bonus if employees don't come back to work Next page： IMF warns Europe against prematurely declaring victory over inflation

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

This bank will cut bonus if employees don't come back to work

Nov 22, 2023

ANZ managers have informed their respective teams about the new policy this week in generic emails, reaffirming the bank's expectation that staff devote at least half their working hours in the office each month, afr.com reported.

IMF warns Europe against prematurely declaring victory over inflation

Nov 8, 2023

The Washington-based IMF said that cost of underestimating inflation’s persistence could be painfully high and result in another painful round of rate hikes that could rob the economy of a large chunk of growth.

Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues

Oct 23, 2023

The airline, which was once considered the pride of Pakistan and was the first international airline to be given access to fly to Beijing, is said to be suffering millions in losses on a daily basis.

Mahindra, Volvo among corporations pushing for fossil fuel exit at COP28

Oct 23, 2023

Companies are increasingly committing to their own timelines for reducing their emissions, but many acknowledge that their ability to slow planet-warming CO2 emissions is contingent on faster action from governments.